A South Korean biotech company is likely to benefit greatly from the policy of the U.S. Food and Drug Administration, which ...

Wellness company Pharmavite, owners of the Nature Made brand, officially opened its 225,000-square-foot, $250 million plant ...

Vice-president JD Vance has said there is a ‘good chance’ a deal could be reached soon, but what are the red lines, and will ...

Bio-Techne on Wednesday beat Wall Street estimates for third-quarter profit, driven by growth in its unit that provides ...

MassBio’s new report outlines several concerns, including NIH cuts undermining the research engine, FDA reductions delaying ...

Imports of pharmaceutical products surged in March, most of which came from Ireland, historically one of the biggest ...

In this interview, rare disease expert Oxana Iliach discusses challenges with rare disease drug development and how they can ...

Commissioners visit UD-based NIIMBL, where public-private partnerships promote innovation, workforce development ...

Chinese biotech LTZ Therapeutics has closed an oversubscribed series ... Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information ...

Sweeping funding cuts threaten to undermine the innovation that has been a central part of US economic strength for decades ...

As per the USFDA, a Class I recall pertains to defective products that can cause serious health problems. In a separate filing, the US health regulator said that a US-based subsidiary of ...

USA), April 25 – 30, at booth #3738 Seoul, South Korea, April 22, 2025 – Meteor Biotech, a specialized spatial omics technology company producing region-targeted cell sorting devices for advanced bio ...